CommentGlobal control of diabetes: information for action
References (13)
- et al.
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
Lancet
(2011) - et al.
Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study
Lancet
(2007) - et al.
Priority actions for the non-communicable disease crisis
Lancet
(2011) Resolution 61/225 World Diabetes Day
- et al.
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
Lancet
(2011) Global alert and response: influenza
Cited by (25)
Single-cell analysis of platelets from patients with periodontitis and diabetes
2023, Research and Practice in Thrombosis and HaemostasisGender difference in diabetes related excess risk of cardiovascular events: When does the ‘risk window’ open?
2017, Journal of Diabetes and its ComplicationsCitation Excerpt :The excess risk for cardiovascular diseases (CVD) associated with diabetes is greater in women than in men, as confirmed by several prospective studies as well as meta-analyses (Norhammar & Schenck-Gustafsson, 2013; Peters, Huxley, Sattar, & Woodward, 2015; Peters, Huxley, & Woodward, 2014a; Peters, Huxley, & Woodward, 2014b; Regensteiner et al., 2015). Although not completely explained, this gender difference has obvious implications in the attempt to optimize preventative and therapeutic interventions due to the well known increase in CV risk conferred by diabetes (Huxley, Barzi, & Woodward, 2006; International Diabetes Federation, 2013; Soedamah-Muthu et al., 2004) and the difference in the incidence rate of the disease between men and women (Peters et al., 2015; Tobias, 2011). Nonetheless, it is yet to be well defined whether the difference between genders is the same for each CV event (i.e. coronary heart disease, stroke, chronic heart failure, lower extremity amputations, etc.) and whether the ‘gender gap’ remains constant through the entire lifespan.
Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants
2015, The Lancet Diabetes and EndocrinologyCitation Excerpt :Population-based health surveys in different countries and at different times have also used different biomarkers for glycaemia and diabetes, and thus define diabetes differently. The variety of biomarkers and definitions creates a challenge in consistently analysing diabetes prevalence across countries and over time, and in measuring what proportion of people with diabetes are diagnosed and receive effective treatments for diabetes and its complications.1,16,17 Therefore, there is a need to understand how the use of different biomarkers and definitions affects the identification of diabetes cases and the resulting estimates of population prevalence.
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM)
2013, Journal of Diabetes and its ComplicationsCitation Excerpt :Diabetes is an increasing public health problem. The UN General Assembly has recognized that diabetes poses risks to well-being worldwide and has calculated that diabetes prevalence has risen by about 7% per decade, from 8.3% in 1980 to 9.8% in 2008 among men, and from 7.5% to 9.2% among women (Tobias, 2011). The number of adults with T2DM worldwide has more than doubled in the last 30 years, rising from 153 million in 1980 to 347 million in 2008 (Danaei et al., 2011).
Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes
2022, Lipids in Health and DiseasePrevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis
2022, Frontiers in Endocrinology